Art

J-GLOBAL ID：201102241648191216   Reference number：11A0986326

SYNTHESIS OF 12,12a-DIHYDRO-7,12a-DIAZACYCLOHEPTA[cd]BENZ[g]AZULEN-12-ONE (CYCLOHEPTA[mn]PYRROLO[2,1-c][1,4]BENZODIAZEPIN-12-ONE) AND EVALUATION OF CYTOTOXIC ACTIVITY AGAINST HeLa S3 CELLS

12,12a-ジヒドロ-7,12a-ジアザシクロヘプタ[cd]ベンズ[g]アズレン-12-オン(シクロヘプタ[mn]ピロロ[1,2-c][1,4]ベンゾジアゼピン-12-オン)の合成およびHeLaS3細胞に対する細胞毒性の評価

Author (7)： YOSHIOKA Eiko (Yamaguchi Univ., Yamaguchi, JPN) ,  FUJII Hiroyuki (Yamaguchi Univ., Yamaguchi, JPN) ,  MURAFUJI Toshihiro (Yamaguchi Univ., Yamaguchi, JPN) ,  IKEDA Reiko (Tokyo Univ. Sci., Chiba, JPN) ,  KONAKAHARA Takeo (Tokyo Univ. Sci., Chiba, JPN) ,  GUNJI Takahiro (Tokyo Univ. Sci., Chiba, JPN) ,  ABE Noritaka (Tokyo Univ. Sci., Chiba, JPN)
Material： Heterocycles  (International Journal for Reviews and Communications in Heterocyclic Chemistry)
Volume： 83  Issue： 6  Page： 1409-1415  Publication year： Jun. 01, 2011 
JST Material Number： S0966A  ISSN： 0385-5414  CODEN： HTCYAM  Document type： Article
Article type： 短報  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *nitrogen heterocyclic compound ,...
Semi thesaurus term： HeLaS3 cell ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A0986326&from=J-GLOBAL&jstjournalNo=S0966A") }}

JST classification (2)： Seven-membered heterocyclic compounds  (CF07110I) ,  Basic research of antitumor(=antineoplastic)drugs  (GW16010A)

Substance index (2)： 2-[(3-Phenyl-1-azaazulene-8-yl)amino]benzoic acid ,  2-Phenyl-7,12a-diaza-12,12a-dihydrobenzo[b]cyclopenta[ef]heptalene-12-one

Reference (10)：

• 1. a) D. E. Thurston, Advanced in the study of Pyrrolo[2,1-c] [1,41benzodiazepine (PBD) Antitumour Antibiotics, in 'Molecular Aspects of Anticancer Drug-DNA Interactions', ed. by S. Neidle and M. Waring, Macmillan Press Ltd., London, 1993, pp. 54-58; b) A. Kamal, M. V. Rao, N. Laxman, G. Ramesh, and G. S. K. Reddy, Curr. Med. Chem.: Anti-Cancer Agents, 2002, 2, 215; c) S. J. Gregson, P. W. Howard, J. A. Hartley, N. A. Brooks, L. J. Adams, T. C. Jenkins, L. R. Kelland, and D. E. Thurston, J. Med. Chem., 2001, 44. 737; d) D. E. Thurston and D. S. Bose, Chem. Rev., 1994, 94, 433; e) D. E. Thurston, 'Chemistry and Pharmacology of Anticancer Drugs' CRC Press, 2006; f) A. Kamal, R. Rajender, D. R. Reddy, M. K. Reddy, G. Balalishan, T. B. Shaik, M. Chourasia, and G. N. Sastry, Bioorg. Med. Chem., 2009, 17, 1557; g) A. Kamal, K. L. Reddy, G. S. K. Reddy, and B. S. N. Reddy, Tetrahedron Lett., 2004, 45, 3499; h) M. Kotecha, J. Kluza, G. Wells, C. C. O'Hare, C. Forni, R. Mantovani, P. W. Howard, P. Mollis, D. E. Thurston, J. A. Hartley, and D. Hochhauser, Mol. Cancer Ther., 2008, 7, 1319; i) N. Cooper, D. R. Hagan, A. Tiberghien, T. Ademefun, C. S. Matthews, P. W. Howard, and D. E. Thurston, Chem. Commun., 2002, 1764; j) P. W. Haward, Z. Chen, S. J. Gregson, L. A. Masterson, A. C. Tiberghien, N. Cooper, M. Fang, M. J. Coffils, S. Klee, J. A. Hartley, and D. E. Thurston, Bioorg. Med. Chem. Lett., 2009, 19, 6463.
• 2. D. Antonow, M. Kaliszczak, G.-D. Kang, M. Coffils, A. C. Tiberghien, N. Cooper, T. Barata, S. Heidelberger, C. H. James, M. Zloh, T. C. Jenkins, A. P. Reszka, S. Neidle, S. M. Guichard, D. I. Jodrell, J. A. Hartley, P. W. Howard, and D. E. Thurston, J. Med. Chem., 2010, 53, 2927, and references cited therein.
• 3. a) N. Abe and T. Gunji, Heterocycles, 2010, 82, 201; b) N. Abe, 'Recent Research Developments in Organic and Bioorganic Chemistry', 2001, 4, 14, Transworld Research Network; c) N. Abe, 'Trends in Heterocyclic Chemistry', 2001, 7, 25, Research Trends; d) T. Nishiwaki and N. Abe, Heterocycles, 1981, 15, 547; e) M. Kimura, Yuki Gosei Kagaku Kyokai Shi, 1981, 39, 690.
• 4. a) M. Nagahara, J. Nakano, M. Miura, T. Nakamura, and K. Uchida, Chem. Pharm. Bull., 1994, 42, 2491; b) M. Nagahara, C. Ieda, M. Miura, K. Uchida, S. Sato, and M. Okumura, Eur. Pat. Appl. EP 376, 233.
• 5. a) T. Ishikawa, T. Saito, S. Noguchi, H. Ishii, S. Ito, and T. Hata, Tetrahedron Lett., 1995, 36, 2795; b) T. Ishikawa, K. Shimooka, T. Narioka, S. Noguchi, T. Saito, A. Ishikawa, E. Yamazaki, T. Harayama, H. Seki, and N. Yamaguchi, J. Org. Chem., 2000, 65, 9143; c) T. Narioka and T. Ishikawa, Heterocycles, 2002, 56, 413; d) T. Ishikawa and A. Zeimoto, Jpn. Kokai Tokkyo Koho, 1999, JP 11255746.

Terms in the title (6)： Cd ,  アズレン ,  Mn ,  HeLaS3細胞 ,  細胞毒性 ,  評価